Posted by Michael Wonder on 06 May 2019
Why one Nova Scotia boy is being treated with drugs that cost $6 million a year despite a better, cheaper alternative
5 May 2019 - Last summer, Health Canada approved a haemophilia drug called Hemlibra that has the potential to change Callum Guthrie’s life – but gaining access to it is proving to be an uphill battle.
When it comes to publicly paid prescription-drug bills, Callum Guthrie might be one of the most expensive patients in Canada.
His parents estimate that the wheelbarrow full of intravenous medications they pick up every two weeks to control their 10-year-old son’s severe haemophilia cost as much as $6-million a year, all of it paid for by Canadian Blood Services.
